The Holmium Platform delivers a first in SIRT: a comprehensive end to end platform for treating unresectable liver tumours.
The Holmium Platform consists of three integrated products that allow you to select patients with confidence, deliver treatment with precision ad plan and verify with accuracy.
QuiremScout™: The first SIRT work-up product that uses the same technology as the therapeutic microspheres, to optimize patient selection and advance treatment planning
Quiremspheres™: The only therapeutic SIRT microsphere that is used as part of a fully integrated platform, to improve patient outcomes and advance the future of SIRT
SIRT with the Holmium Platform
QuiremSpheres™ and QuiremScout™ consist of Holmium-166 microspheres that offer unique imaging capabilities
Q-SuiteTM: dedicated holmium-166 software for individualized treatment planning:
Innovation with Holmium
The short half life of Holmium-166 in QuiremSpheres™ ensures delivery of a high dose rate (90% of radiotherapy dose delivered within 4 days)
Clinical evidence and treatment
Clinical evidence demonstrates that QuiremSpheres™ are efficacious (1) well tolerated (2) and safe (1-3) for the treatment of unresectable liver cancer.“With QuiremSpheres™ we see the majority of our patients responding much quicker than what we are used to seeing with Yttrium-90” Dr. Irene Bargellini, Head of Radiology, Cuneo Hospital
Post-treatment Visualization and Quantification
microspheres allow for post-treatment visualization and quantification using
MRI and SPECT, for further analysis in
Q-SuiteTM“QuiremSpheres™ gives us the confidence we need to start individualizing treatments” Prof.
Ralf-Thorsten Hoffmann, Head of Interventional Radiology, University Hospital
post-treatment dosimetry to verify the radiation dose delivered
QuiremScout® use the same intuitive and efficient administration systemThe
system is easy to learn – it
has been developed in collaboration with leading SIRT physicians and
incorporates features that you may already be familiar with if you have
QuiremSpheresTM is supplied as a standard dose in a single capped V-vial or as a standard dose divided among several capped V-vials.
QuiremSpheres™ is a product manufactured by Quirem Medical B.V. and has CE-mark.
QuiremSpheres™ is not available for sale in all countries. This information is provided only in respect to markets where the product is approved or cleared. QuiremSpheres™ is not FDA cleared in the US for sale.
QuiremSpheres™ is not approved in Canada
Our sales representatives are here for you.
Thank you for contacting us!
We typically respond within 2 business days and will come back to you as soon as possible.
Radifocus™ Guide Wire M Non-Vascular
Radifocus™ Introducer II Radiopaque Marker Kit C
Radifocus™ Guide Wire M Standard Type
Didn't find your product?
This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public
For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.
This is HCP only content
website and cannot be refused. Other cookies are only placed if you choose to do so. For further information, please read our cookies policy.
Essential cookies to ensure the website functions well.
Cookies to help us measure the general use of our website.
Cookies that save personal information while browsing.